Package 63304-724-05

{"route": ["ORAL"], "spl_id": "45fe80b5-18e6-7710-e063-6394a90ad334", "openfda": {"upc": ["0363304724301"], "unii": ["ZG7E5POY8O"], "rxcui": ["993557"], "spl_set_id": ["fddb7191-c4f9-4e82-bd7d-259c3767710a"], "manufacturer_name": ["Sun Pharmaceutical Industries, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "500 TABLET, EXTENDED RELEASE in 1 BOTTLE (63304-724-05)", "package_ndc": "63304-724-05", "marketing_start_date": "20210101"}, {"sample": false, "description": "30 TABLET, EXTENDED RELEASE in 1 BOTTLE (63304-724-30)", "package_ndc": "63304-724-30", "marketing_start_date": "20210101"}, {"sample": false, "description": "90 TABLET, EXTENDED RELEASE in 1 BOTTLE (63304-724-90)", "package_ndc": "63304-724-90", "marketing_start_date": "20210101"}], "brand_name": "Bupropion hydrochloride", "product_id": "63304-724_45fe80b5-18e6-7710-e063-6394a90ad334", "dosage_form": "TABLET, EXTENDED RELEASE", "pharm_class": ["Aminoketone [EPC]", "Dopamine Uptake Inhibitors [MoA]", "Increased Dopamine Activity [PE]", "Increased Norepinephrine Activity [PE]", "Norepinephrine Uptake Inhibitors [MoA]"], "product_ndc": "63304-724", "generic_name": "Bupropion hydrochloride", "labeler_name": "Sun Pharmaceutical Industries, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Bupropion hydrochloride", "active_ingredients": [{"name": "BUPROPION HYDROCHLORIDE", "strength": "300 mg/1"}], "application_number": "ANDA203650", "marketing_category": "ANDA", "marketing_start_date": "20210101", "listing_expiration_date": "20261231"}